2-氨基-5-氯噻吩 | 23474-98-8

• 物质功能分类: 化学试剂 - 有机试剂 - 芳烃
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯硫酚类
• 中文名称: 2-氨基-5-氯噻吩
• 中文别名: 2-氨基-5-氯苯硫醇
• 英文名称: 5-chloro-2-aminobenzenethiol
• 英文别名: 2-amino-5-chlorobenzenethiol；5-chloro-2-aminothiophenol；2-amino-5-chlorothiophenol
• CAS: 23474-98-8
• 化学式: C₆H₆ClNS
• 分子量: 159.639
• InChiKey: TYRZAGMAVZESQX-UHFFFAOYSA-N

物化性质

• 熔点：
  110 °C
• 沸点：
  278.0±20.0 °C(Predicted)
• 密度：
  1.372±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  27
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22
• 海关编码：
  2934999090
• 储存条件：
  室温下密封保存，并确保环境干燥。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Amino-5-chlorothiophenol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-5-chlorothiophenol
CAS number: 23474-98-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H6ClNS
Molecular weight: 159.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基-5-氯噻吩 在 氢氧化钾 、 乙醇 、 sodium acetate 作用下， 以 乙醇 、 丙酮 为溶剂， 反应 11.5h， 生成 1,7-Dichlorophenothiazin
  参考文献：
  名称：

  1- 和 3- 氯-吩噻嗪的合成

  摘要：

  吩噻嗪是通过 Smiles 重排通过 2-氨基-3/5 氯苯硫醇与卤代硝基苯反应合成的。当 Smiles 重排发生原位时，在卤素的两个邻位都具有硝基的卤代硝基苯直接产生吩噻嗪。在卤素邻位具有硝基的卤代硝基苯产生 2-氨基-2'-硝基二苯硫醚，其在与 90% 甲酸的甲酰化作用下产生 2-甲酰氨基-2'-硝基二苯硫醚，其经历 Smiles 重排以提供吩噻嗪。介绍 吩噻嗪显示出显着的药理/生物活性 (1,2)。它们被用作精神安定剂 (3)、镇静剂 (4)、镇痛剂 (5)、抗组胺剂 (6) 等。它们还显示出显着的抗肿瘤活性 (7,8,9,10)。吩噻嗪核中取代模式的轻微改变会导致生物活性的显着差异。因此，它激发了我们合成迄今为止未知的吩噻嗪以寻找更好的药物的兴趣。结果与讨论 2-氨基-3/5-氯苯硫醇采用别处报道的方法(1 l,12)水解裂解制备2-氨基-3/5-氯苯硫醇合成了标题吩噻嗪类化合物(1

  DOI：

  10.1515/hc.2002.8.5.447
• 作为产物：
  描述：

  4-氯苯基硫脲 在 氯仿 、 溴 作用下， 生成 2-氨基-5-氯噻吩
  参考文献：
  名称：

  Synthesis of bioactive substituted pyrazolylbenzothiazinones

  摘要：

  吡唑基苯并噻二嗪酮通过在乙醇存在下2-肼基羰甲基-3,4-二氢-2H-1,4-苯并噻二嗪-3-酮与β-二酮的反应合成，产率良好。通过其分析和光谱数据确定了合成吡唑基苯并噻二嗪酮的结构。合成化合物的抗菌活性也已包含在内。

  DOI：

  10.1007/s11164-014-1727-1

文献信息

• Synthesis and Antifungal Activity of Novel Thiazole-Containing Triazole Antifungals. II. Optically Active ER-30346 and Its Derivatives.
  作者：Akihiko TSURUOKA、Yumiko KAKU、Hiroyuki KAKINUMA、Itaru TSUKADA、Manabu YANAGISAWA、Kazumasa NARA、Toshihiko NAITO

  DOI：10.1248/cpb.46.623

  日期：——

  A series of novel thiazole-containing triazole antifungals was synthesized and evaluated for antifungal activity against a variety of clinically isolated pathogenic fungi in vitro and against systemic candidosis in vivo. These compounds showed potent antifungal activities in vitro and in vivo. In particular, (2R, 3R)-3-[4-(4-cyanophenyl)thiazol-2-yl]-2-(2, 4-difluorophenyl)-1-(1H-1, 2, 4-triazol-1-yl)-2-butanol (12g; ER-30346) showed potent and well-balanced in vitro activities and potent in vivo efficacy, and had a good safety profile.

  一系列含有噻唑结构的三唑类抗真菌药物被合成并评估了它们对临床分离的各种致病真菌的体外抗真菌活性以及对体内系统性念珠菌病的疗效。这些化合物在体内外均显示出强大的抗真菌活性。特别是，(2R, 3R)-3-[4-(4-氰基苯基)噻唑-2-基]-2-(2, 4-二氟苯基)-1-(1H-1, 2, 4-三唑-1-基)-2-丁醇（12g；ER-30346）显示出强大的且平衡良好的体外活性以及强效的体内疗效，并且具有良好的安全性特征。
• [EN] TETRAHYDROBENZOFURO[2,3-C]PYRIDINE AND BETA-CARBOLINE COMPOUNDS FOR THE TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES<br/>[FR] COMPOSÉS DE TÉTRAHYDROBENZOFURO[2,3-C]PYRIDINE ET DE BÊTA-CARBOLINE POUR LE TRAITEMENT, LE SOULAGEMENT OU LA PRÉVENTION DE TROUBLES ASSOCIÉS À DES AGRÉGATS DE PROTÉINE TAU
  申请人：AC IMMUNE SA

  公开号：WO2019233883A1

  公开（公告）日：2019-12-12

  The present invention relates to novel compounds of formula (I) that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).

  本发明涉及一种可以用于治疗、缓解或预防与Tau（微管相关单元）蛋白聚集相关的一组疾病和异常的新化合物（I）的公式。这些疾病和异常包括但不限于神经原纤维缠结（NFTs），如阿尔茨海默病（AD）。
• NOVEL METHINE DYES
  申请人：LANXESS Deutschland Gmbh

  公开号：US20190112486A1

  公开（公告）日：2019-04-18

  The present invention relates to novel methine dyes, methods for the preparation thereof and use thereof for dyeing plastics, especially polyamides, so as to obtain yellow to orange colourings with improved light fastness and improved thermal stability.

  本发明涉及新型甲纶染料，其制备方法和用于染色塑料，特别是聚酰胺，以获得改善光牢度和热稳定性的黄色至橙色着色。
• INHIBITORS OF FATTY ACID AMIDE HYDROLASE
  申请人：INFINITY PHARMACEUTICALS, INC.

  公开号：US20150368278A1

  公开（公告）日：2015-12-24

  The present invention provides compounds, and pharmaceutically acceptable compositions thereof, encompassed by any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof. The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof.

  本发明提供了由任何公式（I）、（II）、（III）、（IV）、（V）或（VI）中的任何化合物及其药学上可接受的组合物所包含的范围，或其亚属所包含的范围。本发明还提供了通过向需要的患者投与任何公式（I）、（II）、（III）、（IV）、（V）或（VI）中的任何化合物或其组合物的治疗有效量来治疗FAAH介导的疾病、紊乱或症状的方法。此外，本发明提供了通过向需要的患者投与任何公式（I）、（II）、（III）、（IV）、（V）或（VI）中的任何化合物或其组合物的治疗有效量来抑制FAAH的方法。
• Antifungal agents, and compositions
  申请人：Eisai Co., Ltd.

  公开号：US05648372A1

  公开（公告）日：1997-07-15

  A compound represented by the general formula: ##STR1## wherein R.sup.1 and R.sup.2 denote a halogen atom or hydrogen atom; R.sup.3 means a hydrogen atom or lower alkyl group; l, r and m stand for 0 or 1; A is N or CH; W denotes an aromatic ring or a condensed ring thereof; X means another aromatic ring, an alkanediyl group, an alkenediyl group, or an alkynediyl group; Y stand for --S--, etc.; Z denotes a hydrogen atom, etc., or a salt thereof, and intermediates thereof or a salt thereof as well as processes for the preparation thereof, and pharmacetical composition suitable for use as an antifungal agent.

  一个由以下一般式表示的化合物：##STR1## 其中R.sup.1和R.sup.2表示卤素原子或氢原子；R.sup.3表示氢原子或较低的烷基基团；l、r和m代表0或1；A为N或CH；W表示芳香环或其缩合环；X表示另一个芳香环、烷二基基团、烯二基基团或炔二基基团；Y代表--S--等；Z表示氢原子等，或其盐，以及其中间体或其盐的制备方法，以及适用作为抗真菌剂的药用组合物。